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of infection in cirrhosis and its diagnostic criteria, risk factors, and
therapeutic algorithms have been deﬁned by consensus [1]. In
contrast, there is large paucity of clinical investigations on sec-
ondary peritonitis in liver cirrhosis in the last two decades and
diagnostic markers for early suspicion as well as parameters
determining outcome are less clear. Peritonitis can be secondary
to perforation or acute inﬂammation of intra-abdominal organs,
abdominal wall infections or previous abdominal surgical proce-
dures or trauma. Except for the latter two, in which the precise
nature of peritoneal infection usually is obvious, the differential
diagnosis between SBP and secondary peritonitis can be very dif-
ﬁcult. In this issue of the Journal of Hepatology, Soriano and co-
workers present a retrospective investigation performed in two
tertiary hospitals in Spain, extending over an observation period
of seven years [2] that helps to re-appraise this important but
often neglected clinical issue. In fact, the observed mortality of
two out of three cirrhotic patients developing secondary peritoni-
tis dying during hospitalization is reported to be signiﬁcantly
higher than in patients with SBP. Mortality found in the latter
group (26.4%) is comparable to previous investigations, but could
have been improved by more a consequent use of albumin [3];
thus, further emphasizing the differences in severity of disease
between the two entities.
With respect to the frequency of secondary peritonitis, in this
largest reported cohort so far 1.25 episodes/year are diagnosed
and thus represent only 4.5% of all peritonitis in cirrhotic ascitic
patients seen at one of the participating institutions. These data
conﬁrm the rarity of secondary peritonitis reported earlier [4]
although others have reported that up to 15% of cirrhotic patients
with peritonitis may have secondary causes [5]. SBP is shown to
occur in more advanced stages of disease as compared to second-
ary peritonitis. This reﬂects the well-known observation that SBPJournal of Hepatology 20
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Open access under CC BY-NC-ND license.develops selectively in patients with low ascitic protein levels
with increasing incidence dependent on further additional risk
factors such as bilirubin >3.2 mg/dL and platelet count <98.000/
mm3 [6,7]. In contrast, secondary peritonitis develops indepen-
dently from the presence and/or severity of cirrhosis.
The observed mortality in cirrhotic patients developing sec-
ondary peritonitis is clearly higher than reports in non-cirrhotic
patient groups, usually remaining below 30% [8]. Thus, it needs
to be emphasized that underlying cirrhosis sets the stage for
fatality. This is due to marked deﬁciencies in local and systemic
host defence mechanisms against bacteria including dysfunction
of cellular and humoral immunity in advanced cirrhosis limiting
peritoneal bacterial clearance. Moreover, ascites per se may con-
tribute to worsen prognosis of any type of peritonitis since in
healthy conditions peritoneal host defence mechanisms are very
efﬁcient, and i.p. injection of various numbers of single organisms
does not cause peritonitis unless adjuvant substances or ascites
are present [9]. Finally, increased porto-systemic shunting as well
as the hyperdynamic circulation with enhanced susceptibility for
hemodynamic instability in case of further vasodilatory stimuli
act in concert to determine the course of disease [10].
The ﬁnding of exaggerated mortality in secondary peritonitis
as compared to SBP is most likely due to the presumably higher
bacterial load and the frequently polymicrobial nature induced
by secondary causes. For instance, experimental cecal ligation
and puncture with prior cecal lavage has been reported to pres-
ent with a 100% survival rate as compared to animals with nor-
mal gut ﬂora, emphasizing the importance of intestinal bacteria
in the development of abdominal sepsis [11]. It is tempting to
speculate that bacterial overgrowth as a well-known feature in
decompensated cirrhosis may additionally contribute to aggra-
vate this scenario in peritonitis due to intestinal perforation.
Moreover, bacterial synergism in polymicrobial infection due to
interaction of two or more bacterial species produces results
which cannot be achieved by an individual bacterial species alone
[12]. In accordance with this concept of ‘‘dose of bacterial bur-
den”, secondary peritonitis was characterized by more leucocyte
recruitment to the peritoneal cavity showing up to threefold
higher levels of ascitic PMN count as compared to SBP. In this
context, the level of pro-inﬂammatory mediators aimed at activa-
tion of leucocytes that enable bacterial clearance are known to
correlate with severity of peritonitis as well as severity of critical
illness and to be predictive for outcome [13,14]. In fact, when
inﬂammatory response becomes overwhelming antibiotics can10 vol. 52 j 7–9
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no longer alter outcome in experimental secondary peritonitis
[15]. The priming of PMN present in advanced cirrhosis in con-
junction with a vast bacterial load in secondary peritonitis may
therefore lead to an excessively pronounced, antibiotic-resistant,
and ultimately fatal systemic inﬂammatory response. In other
words, secondary peritonitis occurring in a decompensated cir-
rhotic patient is like pouring oil into the ﬁre.
However, the outcome of secondary peritonitis in contrast to
SBP is apparently independent from the severity of underlying
liver disease. Despite having major concerns in mind regarding
selection bias, the only variables found to predict survival in
patients with secondary peritonitis were high blood pressure
and high protein concentration in ascites. This clearly points
towards the severity of sepsis determining poor outcome as has
been indicated many times before. However, the authors unfortu-
nately do not report any scoring system usually applied in inten-
sive care medicine, e.g. Sequential Organ Failure Assessment
(SOFA)-based scores. The prognosis in peritonitis has repeatedly
been shown to be decisively inﬂuenced by the health status of
the patient at the beginning of treatment which can be predicted
fairly accurately on the basis of SOFA-derivatives [16]. In fact, in
critically ill cirrhotic patients the SOFA-score has been demon-
strated to exhibit the best predictive ability and to perform better
than liver-speciﬁc scores such as the Child classiﬁcation [17].
Therefore, the use of established prognostic ICU-indices is
strongly recommended and should be implemented more rigor-
ously in hepatology.
Finally, patients being operated on and particularly those with
early intervention tended to have better outcomes. Although not
statistically signiﬁcant and prone to selection bias, it is self-evi-
dent and known since 1889 [18] that early and complete surgical
resolution of the abdominal septic focus is of upmost prognostic
relevance. Soriano et al. indeed observe that all patients with per-
forated secondary peritonitis not undergoing surgery die during
hospitalization. The median time to surgery in the current series
of cases was 3.2 ± 2.4 days in survivors (as compared to 7.2 ±
6.1 days in non-survivors). Therefore, unless the patient is in
pre-terminal or non-operable conditions, delayed diagnostic
work-up is futile, whereas early imaging and surgical interven-
tion increase chances for cure. Conversely, surgical therapy may
be accompanied by signiﬁcant deterioration in the clinical status
of cirrhotic patients with SBP and thus, should be avoided.
Therefore, timing and accuracy of diagnosis correctly separat-
ing SBP and secondary peritonitis is crucial. Clinical signs and
symptoms are clearly not helpful in this regard.
The study by Soriano et al. reinforces suggestions made
beforehand that secondary peritonitis should be suspected when
one of the following criteria is present: (a) no response to antibi-
otic therapy; (b) more than one organism isolated from ascites
and (c) Runyon’s criteria, namely neutrocytic ascites with at least
two of three criteria: ascitic ﬂuid total protein >1 g/dl (in contrast
to SBP which selectively occurs in low-protein ascites), glucose
<50 mg/dl (due to bacterial glucose utilization), or LDH >225
mU/ml (most likely due to more rapid metabolic rate and disin-
tegration of ascitic PMN) [19]. Polymicrobial culture (OR 587.5;
33–10247) followed by Runyon’s criteria (OR 61.2; 6–540) were
the only independent predictive factors associated with second-
ary peritonitis. Moreover, although strata are not stated, the
extreme separating power reported for these parameters (AUC
of ROC curve 0.952) appears to be present at each level of risk.
Uniformly, SBP is reported to be monomicrobial in the vast8 Journal of Hepatology 2majority of cases (88–100%) and hence, polymicrobial ascites
and/or presence of anaerobic bacteria or fungi, usually not
acquired during SBP, clearly indicates the presence of secondary
peritonitis. However, it needs to be stressed that microbiology
results may be obtained too late in the course of disease. Like-
wise, re-paracentesis for control of therapeutic efﬁcacy is mostly
not diagnostic within 12 or 24 h after initiation of antibiotics and
thus is recommended on day two with a PMN cell count reduc-
tion of less than 25% of the initial value deﬁning lack of response
[4]. Therefore, rapid ‘‘chemical” parameters available at the day
of paracentesis with sufﬁcient sensitivity and positive predictive
value are needed for effective screening. Sensitivity of Runyon’s
criteria has been reported to reach 97% in some cohorts [20]
but elsewhere ranges below 68% [2,19] and thus can be opti-
mized. In this regard, Wu et al. have used carcinoembryonic anti-
gen (CEA) present in colonic enterocytes and alkaline
phosphatase (AP) occurring throughout the gastrointestinal tract.
Ascitic elevations in both are not likely to be result of inﬂamma-
tory changes but rather speciﬁc for intestinal perforation. In fact,
ascitic ﬂuid presenting with either AP >240 U/l or CEA >5 ng/ml
in 80% of cases reﬂects peritonitis of secondary origin [21].
Although no data are available on the diagnostic accuracy of com-
bined criteria, fulﬁlling either Wu’s or Runyon’s criteria will most
likely improve sensitivity. In such cases: (i) antibiotic regimen
must include agents against anaerobes and enterococci and (ii)
secondary peritonitis has to be ruled out thoroughly. Therefore,
we strongly recommend initiation of abdominal computer
tomography (CT) as soon as any of these features are present. This
appears to be the only approach to ensure timely diagnosis of
secondary causes; therefore, enabling appropriate surgical treat-
ment. In this regard, data by Soriano et al. underscore the useful-
ness of performing CT since it was diagnostic in more than 91% of
patients. In cases in which CT will be performed without contrast
agent, e.g. in the presence of advanced renal insufﬁciency,
abdominal sonography can clearly add diagnostic power and
should be performed.
In summary, secondary peritonitis in decompensated cirrhosis
is a rare entity that requires the meticulous vigilance of clinicians.
Its occurrence in cirrhosis delivers a devastating prognosis due to
the limited pre-morbid reserves combined with a presumably
overwhelmingly severe systemic inﬂammatory response. Since
the ﬁrst parameter cannot be changed the condition sine qua
non for success is timely diagnosis and surgical intervention to
stop delivery of bacteria and adjuvants into the peritoneal cavity.Financial disclosure
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